Engaging in call options is akin to navigating the convoluted strategies of an American football game. Sometimes, a direct approach serves you best, while at other times, a clever ruse is the winning move.
Essentially, call options constitute a blend of speculation on both time value and intrinsic value. Determining the best approach hinges on an array of factors, including trust in analysts’ price targets and the indications from the derivatives market. Notably, the vigor of various markets could necessitate a change in tactics.
Understandably, we assume that you have diligently performed your research and are keen on the companies listed here. Our focus is on uncovering not only the cheapest options, but also the most economical choices that are likely to yield a profit based on Wall Street’s guidance.
Without further ado, let’s delve into the world of compelling call options.
Unmissable Potential in CoreCivic (CXW)
Source: rawf8/Shutterstock
For investors keen on the private prison enterprise, CoreCivic (NYSE:CXW) presents the CXW Dec 20 ’24 15.00 Call as a compelling option. Among CXW’s unusual options, the $15 call due on December 20 stands out as particularly promising.
Analysts have unanimously rated the shares as a strong buy with an average price target of $17.33. As December approaches, there’s a strong possibility that CXW could trade around $16.88. If the security reaches this price earlier, investors stand to gain significantly. With a Friday closing price of $2.28 and a bid-ask spread of only 9.09% (as represented by the midpoint price), the contract could carry a substantial premium.
Furthermore, political forces might favor CoreCivic, especially with polls suggesting that former President Donald Trump is gaining public trust with his law-and-order narrative. Therefore, a combination of external factors and an enticing price point makes this an option worth considering.
Unlocking Riches with Fusion Pharmaceuticals (FUSN)
Source: Sisacorn / Shutterstock.com
As one of the more obscure entities, Fusion Pharmaceuticals (NASDAQ:FUSN) doesn’t feature an overly robust derivatives market. Nevertheless, it stands as one of the more popular entities, with FUSN posting nearly a 47% gain year-to-date. If investing directly in shares seems precarious, call options offer an attractive alternative.
In my view, the FUSN May 17 ’24 7.50 Call is the optimal choice. Initially, the option may appear costly, with the contract closing at $5.20 on Friday. Multiplying this figure by 100 shares yields a total premium of $520. Even if you exercise the contract – acquiring 100 shares at $7.50 – the total cost of the option amounts to $1,270.
Here’s the beauty of this option: analysts project an average share value of $14.75 by February 2025. By May when the contract expires, shares could reach $13. Consequently, following the contract exercise, even under a worst-case scenario of linear extrapolation of analyst targets, you stand to pocket profits worth $30.
Taking Advantage of Chefs’ Warehouse (CHEF)
Source: Michael Vi / Shutterstock
While the broader market took a downturn last Friday, Chefs’ Warehouse (NASDAQ:CHEF) surged significantly. If you anticipate that the rally will persist, you have two viable options. One involves a traditional straightforward move, while the other is akin to a deceptive maneuver.
Firstly, let’s consider the CHEF Dec 20 ’24 25.00 Call. At first glance, this contract may seem off-putting, given that the market price of CHEF stands at $37.01 at the time of writing. The $25 strike price results in a $13.65 premium. When multiplied by 100 and factoring in the call exercise, the total expenditure is $3,865.
Although seemingly costly, analysts’ average price projection suggests that by December, CHEF could continue its upward trajectory. Analysts predict that by this time, the security could reach
Exploring Intriguing Call Options in the Stock Market
The Smart Investor’s Playbook: Strategic Call Options
As an investor in the stock market, there’s nothing quite like the thrill of call options. It’s akin to playing a game of football, strategizing and making tactical moves to position oneself for the win. Stepping onto the options field requires a keen eye and a calculated game plan. Let’s explore some intriguing call options for three prominent companies – Vale, Halliburton, and Goodyear Tire – and see how the numbers stack up.
Vale (VALE): Evaluating the Playing Field
Source: rafapress / Shutterstock.com
For those eyeing Vale (NYSE: VALE), the options game is on. By January 17, 2025, one could bet on the VALE Jan 17 ’25 5.00 Call with a premium of $8.70 at Friday’s close. Although the initial cost may seem significant, the potential profits loom large. Considering analysts’ average price target of $17.81, the stakes are high, and a play in this arena could yield a handsome profit.
Moreover, those who are in for a more daring maneuver may consider the VALE Jan 17 ’25 $15 strike price, with a contract cost of only 95 cents. This play offers an opportunity to stay in the game and turn a profitable move, even with a seemingly humble outlay. It’s an option worth considering for the savvy investor eyeing potential gains.
Halliburton (HAL): Navigating the Oil Fields
Source: Casimiro PT / Shutterstock.com
At the core of economic trends, Halliburton (NYSE: HAL) stands poised for potential gains. As the second-largest oil service company globally, synergistic growth could be on the horizon. For the investors who believe in this narrative, the HAL Jan 17 ’25 37.00 Call presents an intriguing scenario. With analysts foreseeing HAL stock to reach approximately $46.33 by the expiration date, playing in this field has its allure.
Additionally, the HAL Jan 17 ’25 $42 strike price offers an equally enticing prospect. At a relatively lower premium, this play beckons to those who seek potential gains without emptying their pockets. A careful yet rewarding move for the patient investor.
Goodyear Tire (GT): Tackling the Tire Terrain
Source: Roman Tiraspolsky / Shutterstock.com
When it comes to Goodyear Tire (NASDAQ: GT), the tire industry isn’t exactly a thrill ride. However, dabbling in call options can add a dash of excitement to this seemingly mundane terrain. The GT Jan 17 ’25 15.00 Call emerges as a standout candidate, offering a well-calibrated option play. With a reasonable premium and a potentially bright future at $17.16 per share, it’s a play that balances risk and reward.
Although the GT Jan 17 ’25 $17 call poses a cheaper upfront cost, both plays provide avenues for potential gains and strategic maneuvering. In the call options game, patience and precision can lead to substantial benefits.
Pan American Silver – A Potential Safe Haven in Stubborn Inflationary Environment
The Bullish Case for Pan American Silver (PAAS)
Source: Shutterstock
As inflation continues its relentless ascent, investors seek refuge in assets that have historically acted as hedges. It’s no wonder that Pan American Silver (PAAS) is finding itself under the spotlight. The precious metals mining company stands at the cusp of an unprecedented opportunity in the face of mounting inflation. Moreover, with the burgeoning demand for precious resources, particularly in advanced industries such as electric vehicles, PAAS may have a sound footing in the tumultuous market scenario.
The Bullish Trade: Evaluating Options for PAAS
Speaking of herculean plays, consider the PAAS Jan 17 ’25 8.00 Call. At $13.12, the open market price may appear daunting, but the potential rewards might outweigh the risks. Despite the premium standing at $5.18, suggesting a total layout of $518, the future holds a promising silver lining. Should Wall Street’s consensus target of $20.64 near expiration materialize, exercising shares at the $8 strike would only require a total cost of $1,318. Calculating the potential profit, investors might cheer at a payout of $746 – a sum that should bring a smile to any financially savvy face.
For the more daring speculator, the $17 call with the same expiration date presents an intriguing opportunity. With a premium totaling a modest $115, the gamble seems worthwhile. In the event of the analysts’ consensus materializing and eliminating time value, the cost to exercise this option stands at $1,815, a sum still under the previously deduced $2,064. It’s an audacious bet that might just pay off handsomely.
On the other side of the coin, as of this publication, Josh Enomoto has no vested interest in any securities mentioned. The opinions expressed are solely the author’s and abide by the InvestorPlace.com Publishing Guidelines.







